Passionate about precision medicine and advancing the healthcare industry?

Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus’ proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.

These insights are also experimentally evaluated in our state-of-the-art Biological Modeling Laboratory to accelerate the development of new therapeutic options for patients. We are seeking a Director/Senior Director of Business Development to lead the sales growth of our modeling laboratory services.

What You’ll Do:

• Expand Tempus footprint into pharma and biotech, interfacing with internal and external teams to drive revenue and expanded growth in organoid modeling and other functional genomics modalities

• Sell and contract new projects with customers with limited supervision in a quota-driven environment

• Interface with internal Tempus teams, including marketing, leadership, scientists, and technicians to develop novel 3D organoid models, including high throughput high content imaging assays

• Build upon an existing framework to continuously improve organoid and other patient-derived model-based research

• Drive strategic thinking to create best-in-class organoid and functional genomics platforms

• Engage with commercial and academic strategic partners to create next-gen models representing current unmet needs and indications in oncology

• Collaborate with engineers, computational biologists, data scientists, and machine learning scientists on R&D initiatives both internally and with our pharma partners

Qualifications:

• 5+ years in a fast-paced sales environment with a focus on NGS, oncology, or biomarker technologies

• Demonstrated expertise in tumor modeling, biomarker strategy, and oncology therapy development

• History of meeting and exceeding sales targets and quotas

• Experience with both internal and external projects involving multidisciplinary teams or collaborations

Preferred Candidates will Possess:

• Hands-on experience developing novel protocols, assays, and onboarding new screening technologies including tissue biomarker techniques, cell imaging, 3D cell culture assays, or organoids

• Majority of industrial experience within a drug discovery, CRO services, or technology provider setting

• BS/MS and preferred PhD in Biology

• Ability to function in a fast-paced, cross-functional team environment

• Excellent written and verbal communication skills

• Ability to clearly present and demonstrate Tempus capabilities to cross-functional groups in both small and large formats

LI-GL1 LI-Hybrid $42,500 — $82,500/year